Fertility-female
Conditions
Interventions
Oral Bromocriptine
Sponsors
Irshad Asma
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: This will include consenting and well-motivated infertile women with laboratory evidence of hyperprolactinemia who are ready to comply with study requirements (clinic visits, repeated blood collections, vaginal drug administrations and timely use of medications).
Exclusion criteria
Exclusion criteria: Women with space occupying lesions or other complications requiring urgent intervention, those with active genital tract infections or cancers, renal or hepatic insufficiency, those already on treatment at the time of the study, nonconsenting women and those with allergies to any component of the drugs will be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.Percentage fall in serum prolactin levels during treatment in both arms of the study. 2.Unit drop in prolactin levels in both study groups. 3.Proportion of women who experience side-effects in both arms of the study. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Proportion of women in both arms who achieve symptom relief following treatment. 2. Drug discontinuation rate in both groups. | — |
Countries
Nigeria
Contacts
Public ContactAliyu Sokomba
Senior registrar
Outcome results
None listed